Search
Herpes simplex encephalitis
go.drugbank.com/conditions/DBCOND0013826Drugs: AcyclovirSynonyms: Encephalitis due to HerpesvirusDelgocitinib
go.drugbank.com/drugs/DB16133ApprovedInvestigational[L51913] It works to reduce the inflammatory response in inflammatory skin disorders.[A264703] On July 23, 2025, delgocitinib was also granted approval by the FDA.[L53508] … After the first global approval in Japan,[A264693] delgocitinib was also approved by the European Commission on September 23, 2024.
Neisseria meningitidis group W-135 capsular polysaccharide tetanus toxoid conjugate antigen
go.drugbank.com/drugs/DB15683ApprovedInvestigationalCorneal injuries
go.drugbank.com/conditions/DBCOND0026236Drugs: PrednisoloneSynonyms: Scratch to corneaTuberculosis (TB)
go.drugbank.com/conditions/DBCOND0035963Drugs: Amikacin · Aminosalicylic acid · BCG vaccine · Bacillus calmette-guerin substrain tice live antigen · Capreomycin · Cortisone acetate +7 moreSynonyms: Infection due to Mycobacterium tuberculosisPirbuterol
go.drugbank.com/drugs/DB01291ApprovedWithdrawn-50%. … beta-2 adrenergic receptors are the predominant receptors in bronchial smooth muscle, data indicate that there is a population of beta-2 receptors in the human heart, existing in a concentration between 10
Categories: Agents to Treat Airway DiseaseMedrogestone
go.drugbank.com/drugs/DB09124ApprovedWithdrawn[A31526] It was developed by Ayerst, approved in Canada in 1969 and its current status is cancelled post-marketing.[L1118] It was never approved by the FDA.
Mixtures: PRESOMEN 28 COMP 0.3/5MG, PRESOMEN 28 COMP 0.3/5MGCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesCDX-1135
go.drugbank.com/drugs/DB17607InvestigationalCDX-1135, formerly TP-10, is a soluble, recombinant human Complement Receptor Type 1 (sCR1) developed by Avant Immunotherapeutics (now Celldex).
Salicylate intoxication
go.drugbank.com/conditions/DBCOND0108398Drugs: Sodium bicarbonateSynonyms: Toxicity to various agents